Thalidomide in combination with interferon in the induction therapy for relapsed refractory T-cell lymphoma:two cases report and literature review
10.3760/cma.j.issn.1009-9921.2015.10.006
- VernacularTitle:沙利度胺联合干扰素治疗复发难治T细胞淋巴瘤二例并文献复习
- Author:
Xiaobing XU
;
Xudong WEI
;
Qingsong YIN
;
Ping WANG
;
Hao AI
;
Ruihua MI
;
Lin CHEN
- Publication Type:Journal Article
- Keywords:
Lymphoma,T-cell;
Thalidomide;
Interferon;
Relapsed and refractory
- From:
Journal of Leukemia & Lymphoma
2015;24(10):595-597
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the effectiveness and side-effect of two cases of relapsed and refractory T-cell lymphoma (TCL) treated with thalidomide and interferon.Methods Two cases of relapsed and refractory TCL was treated with thalidomide and interferon, the efficacy and side-effect were observed, and the relevant literature was reviewed.Results The patients achieved partially remission after being treated with thalidomide and interferon.Conclusion Thalidomide in combination with interferon can be used as a second line therapy for relapsed and refractory TCL.
